The OmegaGenesis Medical Advisory Board provides the scientific,
research and medical application guidance in support of the
Company's strategic and scientific directions. Our esteem Medical
Advisory Board is compromised with members from leading medical
institutions serving in our field and scientific disciplines.
"Every 30 seconds someone loses a leg because of diabetes and a
non-healing wound. Most of these occur because of wounds. This
technology may have the potential to alter the balance of power
between healing and amputation."
David G. Armstrong, DPM, MD, PhD, Professor of Surgery, University of Arizona College of Medicine
David G. Armstrong, DPM, MD, PhD, Professor of Surgery, University of Arizona College of Medicine
"Two of the most common causes of death are heart attacks and
strokes. Both of these diseases are increased in patients with
diabetes. The technology OmegaGenesis is developing has the
potential to enhance diabetic wound healing and may prevent death
and disability in these two devastating diseases."
Harold F. Dvorak, MD, Mallinckrodt Distinguished Professor of Pathology Beth Israel Deaconess Medical Center, Boston, MA
Harold F. Dvorak, MD, Mallinckrodt Distinguished Professor of Pathology Beth Israel Deaconess Medical Center, Boston, MA
"Nanoparticles provide unique properties relative to small
molecule therapies, with a wide range of potential therapeutic
applications. The unique properties and utility of nanoparticles
arise from a variety of attributes, including the size of
nanoparticles, that is similar to that of biomolecules such as
proteins and polynucleic acids. The field of nanoparticles in
biology is a burgeoning one, and OmegaGenesis's angiogenic
nanomaterials are uniquely positioned to explore such therapeutic
applications."
Vince Rotelle, PhD, Professor, University of Massachusetts, Amherst, MA
Vince Rotelle, PhD, Professor, University of Massachusetts, Amherst, MA
| Name | Affiliation | Expertise |
|---|---|---|
| Harold Dvorak, MD |
Mallinckrodt Professor of Pathology,
Department of Pathological Anatomy Harvard Medical School |
Angiogenesis, Vascular biology, Tumor biology and Pathology |
| Michael Simons, M.D | Chief of Cardiovascular Medicine at Yale School of Medicine. | Angiogenesis, Vascular biology, Cardiologist |
| Vince Rotello, PhD | Professor, Department of Chemistry University of Massachusetts, Amherst, MA | Supramolecular chemistry of biological and material systems. |
| Mostafa A. El-Sayed, PhD | Julius Brown Chair and Regents Professor of Chemistry and Biochemistry at the Georgia Institute of Technology. |
Nanoscience researcher and a member of the National
Academy of Sciences and a US National Medal of Science laureate.
Distinguished Scholar at the California Institute of Technology
and an Alexander von Humboldt Senior U.S. Scientist Awardee.
He served as editor-in-chief of the Journal of Physical Chemistry from 1980-2004 and the U.S. editor of the International Reviews in Physical Chemistry. He is a Fellow of the American Academy of Arts and Sciences. |
| Edward DeWees, MD | Campbell Family Practice; Los Gatos Community Hospital; Good Samaritan Hospital; Emory University | Family Medical Practitioner with 35 years of experience focused on prevention and human body management; Fellow of American Board of Family Practice; Member American Academy of Family Practice. |
| David Armstrong, DPM, MD, PhD | Professor of Surgery, University of Arizona College of Medicine; Director, Southern Arizona Limb Salvage Alliance (SALSA); and Member of American Board of Podiatric Surgery, 1999. | Dr. Armstrong is a podiatric surgeon and researcher most widely known for his work in amputation prevention, diabetic foot and wound healing. Research areas include wound healing, amputation prevention, infectious diseases, biomechanics, epidemiology of diabetes complications, clinical inflammatory markers (thermography), non-invasive imaging/testing systems, bioinformatics/personal health networks/monitoring. |